Studies on prokinetic, laxative and spasmodic activities of phyllanthus emblica in experimental animals

Phytotherapy Research

Volumn 27, Issue 7, 2013, Pages 1054-1060

  Mehmood, Malik Hassan ^a,b   Rehman, Abdul ^a   Rehman, Najeeb Ur ^a   Gilani, Anwarul Hassan ^a  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Eurphorbiaceae; laxative; muscarinic receptors; Phyllanthus emblica; prokinetic

Indexed keywords

ACETIC ACID ETHYL ESTER; ALKALOID; ATROPINE; CARBACHOL; CHLOROFORM; COUMARIN; EMBLICA OFFICINALIS EXTRACT; FLAVONOID; MUSCARINIC RECEPTOR; PETROLEUM DERIVATIVE; SAPONIN; STEROL; TANNIN; TERPENE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DISEASE MODEL; DRUG ACTIVITY; DRUG POTENCY; DRUG SENSITIVITY; EMBLICA OFFICINALIS; FEMALE; FRUIT; GUINEA PIG; ILEUM; INDIGESTION; INTESTINE CONTRACTION; JEJUNUM; LAXATIVE ACTIVITY; MALE; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PROKINETIC ACTIVITY; RABBIT; SPASMODIC ACTIVITY; TISSUE SECTION;

EURPHORBIACEAE; LAXATIVE; MUSCARINIC RECEPTORS; PHYLLANTHUS EMBLICA; PROKINETIC;

ALKALOIDS; ANIMALS; ATROPINE; CONSTIPATION; COUMARINS; DYSPEPSIA; GUINEA PIGS; ILEUM; JEJUNUM; LAXATIVES; MICE; MUSCLE CONTRACTION; PARASYMPATHOLYTICS; PHYLLANTHUS EMBLICA; PLANT EXTRACTS; RABBITS; RECEPTORS, MUSCARINIC; SAPONINS; STEROLS; TANNINS; TERPENES;

ANIMALIA; CAVIA; MUS; ORYCTOLAGUS CUNICULUS; PHYLLANTHUS EMBLICA;

EID: 84879995014     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4821     Document Type: Article

References (45)

1. Akah PA, Oli, AN, Enwerem, NM, Gamaneil K,. 1997. Preliminary studies on purgative effect of Carica papaya root extract. Fitoterapia 68: 327-331
2. Baquar SR,. 1989. Medicinal and Poisonous Plants of Pakistan. Printas: Karachi, 261.
3. Bhatia J, Tabassum F, Sharma AK, et al,. 2011. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Cardiovasc Toxicol 11: 272-9.
4. Brown JH, Taylor P,. 2006. Cholinergic agonists in: The Pharmacological Basis of Therapeutics, Brunton LL, Lazo JS, Parker KL, (eds.), 11th (ed). McGraw-Hill: New York, 183-200.
5. Chalise JP, Acharya K, Gurung N, et al,. 2010. Antioxidant activity and polyphenol content in edible wild fruits from Nepal. Int J Food Sci Nut 61: 425-432.
6. Chen TS, Liou SY, Chang YL,. 2009. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients. Am J Chin Med 37: 19-25.
7. Duke JA, Bogenschutz-Godwin MJ, Du celliar J, Duke PAK,. 2002. Handbook of Medicinal Herbs, 2nd (ed). CRC Press: Boca Raton, 317.
8. Duke JA,. 1992. Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants, 2nd (ed). CRC Press: London, 335.
9. El-Desouky SK, Ryu SY, Kim YK,. 2008. A new cytotoxic acylated apigenin glucoside from Phyllanthus emblica L. Nat Prod Res 22: 91-95.
10. Evans WC,. 2006. Trease and Evans Pharmacognosy, 5th (ed). Elsevier, Delhi, 135-150.
11. Ghayur MN, Gilani AH, Houghton PJ,. 2005. Species differences in the gut stimulatory effects of radish seeds. J Pharm Pharmacol 57: 1493-1501.
12. Gilani AH, Shaheen F, Christopoulos A, Mitchelson F,. 1997. Interaction of ebeinone, an alkaloid from Fritillaria imperialis, at two muscarinic acetylcholine receptor subtypes. Life Sci 60: 535-544.
13. Hoogerwerf WA, Pasricha PJ,. 2006. Pharmacotherapy of gastric acidity, peptic ulcer and gastroesophagial reflux disease. In: The pharmacological basis of therapeutics., Brunton LL, Lazo JS, Parker KL, (eds.). 11th (ed). McGraw-Hill: New York, 967-981.
14. Huabprasert S, Kasetsinsombat K, Kangsadalampai K, et al,. 2012. The Phyllanthus emblica L. infusion carries immunostimulatory activity in a mouse model. J Med Assoc Thai 2: S75-82.
15. Itthipanichpong C, Ousavaplangchai L, Ramart S, Thamaree S, Tankeyoon M,. 1987. Acute toxicity and subacute toxicity study of Phyllanthus emblica. Chula Med J 31: 367-376.
16. Jaijoy K, Soonthornchareonnon N, Lertprasertsuke N, Panthong A, Sireeratawong S,. 2010. Acute and chronic oral toxicity of standardized water extract from the fruit of Phyllanthus emblica Linn. Int J Appl Res Nat Product 3: 48-58.
17. Kerr PM, Hillier K, Wallis RM, Garland CJ,. 1995. Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon. Br J Pharmacol 115: 1518-1524.
18. Krishnaveni M, Mirunalini S,. 2010. Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder. J Basic Clin Physiol Pharmacol 21: 93-105.
19. 3 nor sesquiterpenoids from the roots of Phyllanthus emblica. J Nat Prod 72: 969-972.
20. Majeed M, Bhat B, Jadhav AN, Srivastava JS, Nagabhushanam K,. 2009. Ascorbic acid and tannins from Emblica officinalis Gaertn. Fruits-a revisit. J Agr Food Chem 57: 220-225.
21. Mascolo N, Izzo AA, Avtore G, Barboto F, Capasso F,. 1994. Nitric oxide and castor oil- induced diarrhea. J Pharmacol Exp Ther 268: 291-295.
22. 3 receptor activation. Eur J Pharmacol 259: 211-214.
23. Mehmood MH, Gilani AH,. 2010. Pharmacological basis for the use of black pepper and piperine in gastrointestinal disorders. J Med Food 13: 1086-1096.
24. Mehmood MH, Aziz N, Ghayur MN, Gilani AH,. 2010. Pharmacological basis for the medicinal use of Psyllium husk (Ispaghula) in constipation and diarrhea. Dig Dis Sci 56: 1460-1471.
25. Mehmood MH, Siddiqi HS, Gilani AH,. 2011. The antidiarrheal and spasmolytic activities of Phyllanthus emblica Linn.are mediated through dual blockade of muscarinic receptors and Calcium channels. J Ethnopharmacol 133: 856-865.
26. Nadkarni KM,. 1986. Indian Materia Medica, 3rd revised and enlarged (ed). Popular Prakashan, Bombay, 736-737.
27. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, DC, 1-5.
28. Nicolis E, Lampronti I, Dechecchi MC, et al,. 2008. Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. Int Immun 8: 1672-1680.
29. Norman R, Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z,. 1985. Medicinal plants in therapy. Bull World Health Organ 63: 965-981
30. Pasricha PJ,. 2006. Treatment of disorders of bowel motility and water Flux, In: The Pharmacological Basis of Therapeutics, Brunton LL, Lazo JS, Parker KL, (eds). 11th (ed). McGraw-Hill: New York, 983-1008.
31. Raj K, Goyal MD,. 1988. Identification, localization and classification of muscarinic receptor subtypes in the gut. Life Sci 43: 2209-2220.
32. Rehman NU, Mehmood MH, Alkharfy KM, Gilani AH,. 2011. Laxative effect of Lepidium sativum seed extract with species and tissue selective gut stimulatory activities. J Ethnopharmacol 134: 878-883.
33. Rehman NU, Mehmood MH, Al-Rehaily AJ, Mothana RA, Gilani AH,. 2012. Species and tissue-specificity of prokinetic, laxative and spasmodic effects of Fumaria parviflora. BMC Comp Altern Med 12: 16.
34. Ruff RL, Secrist D,. 1984. Inhibitors of prostaglandin synthesis or cathepsin B prevent muscle wasting due to sepsis in the rat. J Clin Invest 73: 1483-1486.
35. Sabina EP, Rasool M,. 2007. Analgesic, antipyretic and ulcerogenic effects of Indian Ayurvedic herbal formulation Trifla. Res J Med Plant 1: 54-59.
36. 1-selective antagonist, and other ocularly employed antihistamines. Drug Develop Res 33: 448-453.
37. Sharma A, Sharma MK, Kumar M,. 2009. Modulatory role of Emblica officinalis fruit extract against arsenic induced oxidative stress in Swiss albino mice. Chem Bio Inter 180: 20-30.
38. Singh DP, Govindarajan R, Rawat AK,. 2008. High-performance liquid chromatography as a tool for the chemical standardisation of Triphala-an Ayurvedic formulation. Phy Anal 19: 164-8.
39. Srirama R, Deepak HB, Senthilkumar U, et al,. 2012. Hepatoprotective activity of Indian Phyllanthus. Pharm Biol 50: 948-953.
40. Thakur RS, Puri HS, Husain A,. 1989. Major Medicinal Plants of India. CIMAP: Lucknow, India.
41. Tobin G, Giglio D, Lundgren O,. 2009. Muscarinic receptor subtypes in the alimentary tract. J physio pharmacol 60: 3-21.
42. Wien R, Mason DF, Edge ND, Langston GT,. 1952. The ganglion blocking properties of homologous compounds in the methonium series. Br J Pharmacol Chemother 7: 534-541.
43. Williamson EM, Okpako DT, Evans FJ,. 1998. Pharmacological Methods in Phytotherapy Research. JohnWiley & Sons: Chichester, 15-23.
44. World Health Organization (WHO). 2000. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. 1211 Geneva 27, Switzerland (80 pages).
45. Xia Q, Xiao P, Wan L, Kong J,. 1997. Ethnopharmacology of Phyllanthus emblica L. Zhongguo Zhong Yao Za Zhi 22: 515-518, 525, 574.